Paul Tudor Jones’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$286K Sell
23,854
-456
-2% -$3.78K ﹤0.01% 3156
2026
Q1
$204K Hold
24,310
﹤0.01% 3365
2025
Q4
$350K Buy
+24,310
New +$303K ﹤0.01% 2943
2025
Q2
Sell
-24,123
Closed -$172K 3676
2025
Q1
$172K Buy
+24,123
New +$179K ﹤0.01% 2892
2024
Q4
Sell
-24,815
Closed -$260K 3429
2024
Q3
$260K Sell
24,815
-1,592
-6% -$19.4K ﹤0.01% 2397
2024
Q2
$309K Buy
+26,407
New +$411K ﹤0.01% 1997
2023
Q4
Sell
-22,694
Closed -$374K 2813
2023
Q3
$374K Buy
22,694
+9,639
+74% +$175K ﹤0.01% 1823
2023
Q2
$261K Sell
13,055
-12,397
-49% -$239K ﹤0.01% 2077
2023
Q1
$481K Buy
25,452
+14,342
+129% +$317K 0.01% 1639
2022
Q4
$252K Sell
11,110
-2,791
-20% -$63.1K 0.01% 2014
2022
Q3
$367K Buy
+13,901
New +$412K 0.01% 1632
2022
Q2
Sell
-12,317
Closed -$409K 2454
2022
Q1
$409K Buy
+12,317
New +$342K 0.01% 1389
2021
Q2
Sell
-12,768
Closed -$436K 1885
2021
Q1
$436K Buy
+12,768
New +$545K 0.01% 1184
2017
Q2
Sell
-50,730
Closed -$979K 1322
2017
Q1
$979K Buy
+50,730
New +$978K 0.03% 391
2015
Q4
Sell
-31,150
Closed -$686K 1802
2015
Q3
$686K Buy
+31,150
New +$795K 0.02% 577

Other funds holding RGNX

Paul Tudor Jones's RGNX Position: Q2 2026 in Review

Paul Tudor Jones reduced its Regenxbio (RGNX) stake by 1.9% in Q2 2026, selling an estimated $3.78K and leaving 23,854 shares worth $286K. The position accounts for ﹤0.01% of the portfolio, ranked #3156.

Paul Tudor Jones first reported a position in RGNX in Q3 2015 and has held it in 15 quarters since. The position peaked at $979K in Q1 2017. 164 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Paul Tudor Jones held 23,854 shares of Regenxbio worth $286K as of Q2 2026.
  • Paul Tudor Jones sold 456 Regenxbio shares in Q2 2026, an estimated $3.78K.
  • Regenxbio made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #3156 holding.
  • Paul Tudor Jones first reported a position in Regenxbio in Q3 2015 and has held it in 15 quarters since.
  • Paul Tudor Jones's Regenxbio position peaked at $979K in Q1 2017.
  • 164 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.